Trial Profile
A Retrospective, Multicentre, Comparative Study Evaluating the Efficacy of Rivaroxaban Versus Nadroparin for Preventing Deep Venous Thrombosis (DVT) in Elderly Patients with Osteoporosis Undergoing Initial Total Hip Arthroplasty (THA) for Femoral Neck Fractures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Nadroparin calcium (Primary) ; Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 26 Mar 2018 New trial record